Mar 29, 2023 08:00 AM

Tasly Pharmaceutical Group Co.,Ltd. Posted 340.8 Million Yuan Net Loss in 2022

By Caixin Automation

Tasly Pharmaceutical Group Co.,Ltd. (天士力医药集团股份有限公司) (600535.SH) reported a net loss of 340.8 million yuan in 2022, reversing a net profit of 2.4 billion yuan for the previous year.

Meanwhile, the company posted 8.6 billion yuan in revenue, up 8.1% year-on-year.

At the end of the reporting period, it had 16.4 billion yuan in total assets and 3.8 billion yuan in total liabilities, with a liability-to-asset ratio of 22.9%.

Share this article

Open WeChat and scan the QR code

GALLERY

: Gallery: Powerful Quake Strikes Off Japan

NEWSLETTERS

Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription

PODCAST

China Business Uncovered Podcast: Brazil’s ‘Very Chinese Moment’

00:00

00:00/00:00

MOST POPULAR

1: Luckin-Backer Centurium Capital to Buy Blue Bottle Coffee From Nestlé

2: Two Sessions: With 4.5%-5% Growth Target, China Aims to Create Space for Reform

3: China Business Uncovered Podcast: Brazil’s ‘Very Chinese Moment’

4: Cover Story: How China’s Growing Gig Economy Has Left a Generation Adrift

5: First Tanker Crosses Strait of Hormuz Since Iran’s Closure Threat

SPONSORED

OR